Relief Therapeutics

Supporting patients through science and innovation


Relief Therapeutics is a drug development company focusing on clinical stage projects, primarily developing drugs of natural human origin (peptides and proteins) with a history of clinical testing and use in human patients.

Currently Relief Therapeutics concentrates its initial efforts on diabetic complicationsrespiratory diseases and allergies. Additional MPCs and indications will be considered as opportunities arise.

Relief has also focuses its efforts in the development and commercialization of the two programs acquired from Genclis SA: production of non-hydrolysed hypoallergenic cow milk and artificial colostrum for the potential prevention and treatments of allergies and related diseases.

Current Pipeline
Relief places a special emphasis to rapidly deliver on these programs with the highest priority.

In collaboration with   Genclis SA  –  Health&Happiness  –  University of Freiburg DE